Sczesnak A, Segata N, Qin X, et al. The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe. 2011;10(3):260-72. doi:10.1016/j.chom.2011.08.005
Rohland N, Reich D. Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture. Genome Res. 2012;22(5):939-46. doi:10.1101/gr.128124.111
Barretina J, Caponigro G, Stransky N, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603-7. doi:10.1038/nature11003
Nyman ES, Loukola A, Varilo T, et al. Sex-specific influence of DRD2 on ADHD-type temperament in a large population-based birth cohort. Psychiatr Genet. 2012;22(4):197-201. doi:10.1097/YPG.0b013e32834c0cc8
Berger MF, Hodis E, Heffernan TP, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature. 2012;485(7399):502-6. doi:10.1038/nature11071
Briggs AW, Rios X, Chari R, et al. Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res. 2012;40(15):e117. doi:10.1093/nar/gks624
Neafsey DE, Galinsky K, H Y Jiang R, et al. The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat Genet. 2012;44(9):1046-50. doi:10.1038/ng.2373
Hyman SE. Target practice: HDAC inhibitors for schizophrenia. Nat Neurosci. 2012;15(9):1180-1. doi:10.1038/nn.3200
Jalili A, Wagner C, Pashenkov M, et al. Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma. J Natl Cancer Inst. 2012;104(21):1673-9. doi:10.1093/jnci/djs373
Noseworthy PA, Peloso GM, Hwang SJ, et al. QT interval and long-term mortality risk in the Framingham Heart Study. Ann Noninvasive Electrocardiol. 2012;17(4):340-8. doi:10.1111/j.1542-474X.2012.00535.x